Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D N Shcherbinin

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Molekuliarnaia Biologiia|February 19, 2025
[Identification of the Clinical Isolate CCGC 19/16 as Bacillus cytotoxicus]N B Polyakov, D S Karpov, M V Zubasheva, et al.
Voprosy Virusologii|October 3, 2024
Development, study, and comparison of models of cross-immunity to the influenza virus using statistical methods and machine learningM N Asatryan, I S Shmyr, B I Timofeev, et al.
Acta Naturae|June 1, 2012
Induction of a Protective Heterosubtypic Immune Response Against the Influenza Virus by using Recombinant Adenoviral Vectors Expressing Hemagglutinin of the Influenza H5 VirusM M Shmarov, E S Sedova, L V Verkhovskaya, et al.
Voprosy Virusologii|July 12, 2023
[Mathematical model for assessing the level of cross-immunity between strains of influenza virus subtype H<sub>3</sub>N<sub>2</sub>]M N Asatryan, B I Timofeev, I S Shmyr, et al.
Molekuliarnaia Biologiia|August 2, 2023
[Identification of Clinical Isolates of the Bacillus cereus Group and Their Characterization by Mass Spectrometry and Electron Microscopy]T A Smirnova, N B Polyakov D S Karpov, A I Solovyev, et al.
Acta Virologica|November 5, 2020
Variability of nonpathogenic influenza virus H5N3 under immune pressureT A Timofeeva, I A Rudneva, G K Sadykova, et al.
Acta Naturae|February 7, 2022
Nanobodies Are Potential Therapeutic Agents for the Ebola Virus InfectionI B Esmagambetov, D V Shcheblyakov, D A Egorova, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Molekuliarnaia Biologiia|February 19, 2025
[Identification of the Clinical Isolate CCGC 19/16 as Bacillus cytotoxicus]N B Polyakov, D S Karpov, M V Zubasheva, et al.
Voprosy Virusologii|October 3, 2024
Development, study, and comparison of models of cross-immunity to the influenza virus using statistical methods and machine learningM N Asatryan, I S Shmyr, B I Timofeev, et al.
Acta Naturae|June 1, 2012
Induction of a Protective Heterosubtypic Immune Response Against the Influenza Virus by using Recombinant Adenoviral Vectors Expressing Hemagglutinin of the Influenza H5 VirusM M Shmarov, E S Sedova, L V Verkhovskaya, et al.
Voprosy Virusologii|July 12, 2023
[Mathematical model for assessing the level of cross-immunity between strains of influenza virus subtype H<sub>3</sub>N<sub>2</sub>]M N Asatryan, B I Timofeev, I S Shmyr, et al.
Molekuliarnaia Biologiia|August 2, 2023
[Identification of Clinical Isolates of the Bacillus cereus Group and Their Characterization by Mass Spectrometry and Electron Microscopy]T A Smirnova, N B Polyakov D S Karpov, A I Solovyev, et al.
Acta Virologica|November 5, 2020
Variability of nonpathogenic influenza virus H5N3 under immune pressureT A Timofeeva, I A Rudneva, G K Sadykova, et al.
Acta Naturae|February 7, 2022
Nanobodies Are Potential Therapeutic Agents for the Ebola Virus InfectionI B Esmagambetov, D V Shcheblyakov, D A Egorova, et al.
Pageof 2